These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36251509)

  • 1. Co-amorphous Systems of Sinomenine with Platensimycin or Sulfasalazine: Physical Stability and Excipient-Adjusted Release Behavior.
    Chen X; Li D; Zhang H; Duan Y; Huang Y
    Mol Pharm; 2022 Nov; 19(11):4370-4381. PubMed ID: 36251509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-amorphous systems of sinomenine with nonsteroidal anti-inflammatory drugs: A strategy for solubility improvement, sustained release, and drug combination therapy against rheumatoid arthritis.
    Chen X; Li D; Zhang H; Duan Y; Huang Y
    Int J Pharm; 2021 Sep; 606():120894. PubMed ID: 34280485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platensimycin-berberine chloride co-amorphous drug system: Sustained release and prolonged half-life.
    Wang Z; Chen X; Li D; Bai E; Zhang H; Duan Y; Huang Y
    Eur J Pharm Biopharm; 2022 Oct; 179():126-136. PubMed ID: 36087879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tranilast-matrine co-amorphous system: Strong intermolecular interactions, improved solubility, and physiochemical stability.
    Hu D; Chen X; Li D; Zhang H; Duan Y; Huang Y
    Int J Pharm; 2023 Mar; 635():122707. PubMed ID: 36764418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sinomenine-phenolic acid coamorphous drug systems: Solubilization, sustained release, and improved physical stability.
    Chen X; Li D; Zhang H; Duan Y; Huang Y
    Int J Pharm; 2021 Apr; 598():120389. PubMed ID: 33609724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino acids as co-amorphous excipients for tackling the poor aqueous solubility of valsartan.
    Huang Y; Zhang Q; Wang JR; Lin KL; Mei X
    Pharm Dev Technol; 2017 Feb; 22(1):69-76. PubMed ID: 27050301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-amorphous formulation of dipyridamole with p-hydroxybenzoic acid: Underlying molecular mechanisms, physical stability, dissolution behavior and pharmacokinetic study.
    Guo W; Dong X; Li Y; Li C; Tian Y; Gao H; Li T; Zhu H; Wang J; Yang C
    Eur J Pharm Biopharm; 2023 Mar; 184():139-149. PubMed ID: 36709922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
    Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
    J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acids as co-amorphous excipients for simvastatin and glibenclamide: physical properties and stability.
    Laitinen R; Löbmann K; Grohganz H; Strachan C; Rades T
    Mol Pharm; 2014 Jul; 11(7):2381-9. PubMed ID: 24852326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of co-amorphous Ritonavir-Indomethacin systems by solvent evaporation technique: improved dissolution behavior and physical stability without evidence of intermolecular interactions.
    Dengale SJ; Ranjan OP; Hussen SS; Krishna BS; Musmade PB; Gautham Shenoy G; Bhat K
    Eur J Pharm Sci; 2014 Oct; 62():57-64. PubMed ID: 24878386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-Excipient Interactions: Effect on Molecular Mobility and Physical Stability of Ketoconazole-Organic Acid Coamorphous Systems.
    Fung MH; DeVault M; Kuwata KT; Suryanarayanan R
    Mol Pharm; 2018 Mar; 15(3):1052-1061. PubMed ID: 29309158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Co-amorphous technology to improve dissolution and physical stability of silybin].
    Liu H; Zhao GW; Jiang QY; Liang XL; Ouyang LQ; Ding HB; Chen XL; Liao ZG
    Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(1):103-110. PubMed ID: 35178916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance comparison between crystalline and co-amorphous salts of indomethacin-lysine.
    Kasten G; Nouri K; Grohganz H; Rades T; Löbmann K
    Int J Pharm; 2017 Nov; 533(1):138-144. PubMed ID: 28947246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of co-grinded mixtures of aceclofenac and neusilin US2 for dissolution enhancement of aceclofenac.
    Vadher AH; Parikh JR; Parikh RH; Solanki AB
    AAPS PharmSciTech; 2009; 10(2):606-14. PubMed ID: 19444620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissolution and Solubility Enhancement of the Highly Lipophilic Drug Phenytoin via Interaction with Poly(N-isopropylacrylamide-co-vinylpyrrolidone) Excipients.
    Widanapathirana L; Tale S; Reineke TM
    Mol Pharm; 2015 Jul; 12(7):2537-43. PubMed ID: 26046484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The development of co-amorphous drug systems].
    Yao J; Shi NQ; Wang XL
    Yao Xue Xue Bao; 2013 May; 48(5):648-54. PubMed ID: 23888685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Desloratadine-Benzoic Acid Co-Amorphous Solid: Preparation, Characterization, and Stability Evaluation.
    Ainurofiq A; Mauludin R; Mudhakir D; Soewandhi SN
    Pharmaceutics; 2018 Jul; 10(3):. PubMed ID: 29986403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.